Is Watch and Wait Still Standard for Indolent Atl?
نویسندگان
چکیده
منابع مشابه
Is watch and wait still acceptable for patients with low-grade follicular lymphoma?
Follicular lymphoma (FL) represents more than 20% of all non-Hodgkin lymphomas worldwide and approximately 30% of the non-Hodgkin lymphomas diagnosed in the United States. Although occasionally localized at the time of diagnosis, most patients have disseminated disease. However, patients are frequently asymptomatic, and this, in combination with a long median survival, led to the initial studie...
متن کاملTreatment of indolent lymphomas from watch and wait to high dose therapy.
Indolent B-cell non-Hodgkin’s lymphomas (IBCNHL) represent a heterogenous group of chronic diseases [1]. Follicular lymphomas grades 1 and 2 (FL1/2) are by far the most common, accounting for approximately 20% of all NHL worldwide. Indolent IBC-NHL also include small lymphocytic lymphoma (SLL), which is the tissue counterpart of B-chronic lymphocytic leukemia (B-CLL); [2], lymphoplasmacytic lym...
متن کاملSimulating watch and wait for rectal cancer.
for decades, it has been accepted that surgical resection is the cornerstone for the curative treatment of rectal cancer. Conventional treatment for patients with locally advanced stages ii and iii rectal cancers has included preoperative radiation with concurrent chemotherapy, before radical resection, to improve local control. unfortunately, surgery is not without its risk for serious complic...
متن کاملWatch and wait after neoadjuvant therapy for rectal cancer.
One of the most exciting, although contentious, areas of rectal cancer management in the past decade has been complete response after neoadjuvant chemoradiotherapy (CRT) with a ‘watch-and-wait’ policy in selected patients. Recent publications1–3 have added considerably to our knowledge on this complex topic, where sustained clinical, endoscopic and radiological response allows the consideration...
متن کاملWait still on for antimicrobial surveillance.
Fifteen months after the Public Health Agency of Canada (PHAC) terminated its national committee dedicated to tackling antibiotic resistance, the federal government continues to resist calls for a new national surveillance mechanism. Rather, experts say the government continues to encourage antibiotic surveillance efforts funded by drug companies and as with many files, appears content to leave...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of Oncology
سال: 2014
ISSN: 0923-7534
DOI: 10.1093/annonc/mdu417.1